30 min listen
Ep 902 | How Government and Corporate Control of Medicine Censored COVID Treatment | Guest: Dr. Mobeen Syed
Ep 902 | How Government and Corporate Control of Medicine Censored COVID Treatment | Guest: Dr. Mobeen Syed
ratings:
Length:
66 minutes
Released:
Jun 25, 2021
Format:
Podcast episode
Description
America’s medical system, along with most doctors, was not prepared to think outside the box to treat COVID, according to today’s guest. Dr. Mobeen Syed is founder of DrBeen, a medical education program designed to train today’s doctors in medical innovation. He is one of the doctors who has promoted ivermectin and other therapeutics to treat COVID and has faced censorship. He believes that the corporate/government monopoly on medicine has boxed out the doctors who seek to innovate. He also discusses the mechanics of ivermectin and some of the growing concerns about the vaccines and the way they are marketed. Dr. Syed is working on a plan to create alternative information sources outside the polluted pipeline of the medical establishment.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
Released:
Jun 25, 2021
Format:
Podcast episode
Titles in the series (100)
Primary Preview & Holding the Line On Obama's SCOTUS Nominee - Ep. 22: Upcoming Primaries Daniel goes over the road ahead for the GOP primary and discusses some delegate math. At this point, the best chance to stop Trump is for Kasich to drop, as has been said time and time again, but barring that Cruz does have the ability to win some important states and walk away with an argument and mandates heading into the convention. Arizona & Utah are closed primaries. Will this first chance for Cruz to run in a narrowed filed, in closed primaries show his strength? Will early voting hurt in Arizona where some numbers have almost 55% of the people voting early? Kasich: He doesn’t have a path to win another state, let along a plurality – what is his end game? SCOTUS Nominee It looks like Senate GOP leadership may hold the line on the SCOTUS nominee, but they are so unfamiliar with such principled stands that they come off looking awkward and goofy. Can they unify in message or will it come by Conservative Review with Daniel Horowitz